These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 181215)

  • 21. [Comparative studies on antibiotic susceptibility in Serratia marcescens].
    Gulino R; Modde H
    Schweiz Rundsch Med Prax; 1973 Apr; 62(14):428-31. PubMed ID: 4572075
    [No Abstract]   [Full Text] [Related]  

  • 22. Nonspecific resistance of Serratia marcescens against antimicrobial drugs. Resistance or decreased susceptibility of phenotypic variants against chloramphenicol, nalidixic acid, nitrofurantoin, sulfonamides and trimethoprim.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(4):196-203. PubMed ID: 378575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of a seven-drug-resistance plasmid in two strains of Salmonella typhi murium from diarrheatic patients.
    Hocmanová M; Krcméry V
    Zentralbl Bakteriol Orig A; 1974; 229(2):277-8. PubMed ID: 4155876
    [No Abstract]   [Full Text] [Related]  

  • 24. Serratia marcescens bacteremia. Clinical observations and studies of precipitin reactions.
    Crowder JG; Gilkey GH; White AC
    Arch Intern Med; 1971 Aug; 128(2):247-253. PubMed ID: 4998276
    [No Abstract]   [Full Text] [Related]  

  • 25. An R plasmid of Serratia marcescens transferable to Pseudomonas aeruginosa.
    Olexy VM; Mucha DK; Bird TJ; Grieble HG; Farrand SK
    Chemotherapy; 1982; 28(1):6-17. PubMed ID: 6276109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Segregation during transfer of infectious drug resistance in Enterobacteriaceae.
    Walton JR; Fulton F
    Nature; 1967 Jul; 215(5097):179-80. PubMed ID: 4860507
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current status of general antibiotic therapy].
    Tauchnitz C
    Zentralbl Chir; 1973 Jun; 98(22):801-7. PubMed ID: 4353968
    [No Abstract]   [Full Text] [Related]  

  • 28. [Development of resistance to nalidixic acid in experiments in vitro and cross resistance with other preparation in pathogenic and nonpathogenic strains of E. coli].
    Andreeva AM; Moroz AF
    Antibiotiki; 1968 Aug; 13(8):703-8. PubMed ID: 4301188
    [No Abstract]   [Full Text] [Related]  

  • 29. Analysis of neomycin, kanamycin, tobramycin and amikacin resistance mechanisms in gentamicin-resistant isolates of Enterobacteriaceae.
    Adwan K; Abu-Hasan N; Al-Asmar H
    J Med Microbiol; 1998 Nov; 47(11):1019-21. PubMed ID: 9822302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmid-independent resistance of 'gray' colony variants of a strain of Serratia marcescens resistant to amikacin, cefotaxime and lamoxactam.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1983; 29(4):265-74. PubMed ID: 6307604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rifampicin: a bacteriostatic and bactericidal agent].
    Baudens JG; Chabbert YA
    Pathol Biol (Paris); 1969 Apr; 17(7):392-7. PubMed ID: 4307548
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibacterial activity of tobramycin against gram-negative bacteria and the combination of ampicillin/tobramycin against E. coli.
    Laxer RM; Mackay E; Marks MI
    Chemotherapy; 1975; 21(2):90-8. PubMed ID: 168040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonspecific aminoglycoside cross-resistance of Serratia marcescens.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(4):204-13. PubMed ID: 378576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Selection of chemotherapeutic agents for the resistance determination of fast growing bacteria (minimal requirements)].
    Dtsch Med Wochenschr; 1972 Feb; 97(8):303-4. PubMed ID: 4333596
    [No Abstract]   [Full Text] [Related]  

  • 35. A probable example of R-factor recombination in the human gastro-intestinal tract.
    Ingram LC; Anderson JD; Arrand JE; Richmond MH
    J Med Microbiol; 1974 May; 7(2):251-7. PubMed ID: 4599665
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antibiotic sensitivity of gram-negative bacilli isolated from lesions since 1965].
    Yamaji Y; Takahashi M; Miyanaga Y; Todome Y; Motoyama M
    Jpn J Antibiot; 1968 Feb; 21(1):25-33. PubMed ID: 4174373
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibiotic-resistant gram-negative bacilli in the faeces of neonates.
    Noy JH; Ayliffe GA; Linton KB
    J Med Microbiol; 1974 Nov; 7(4):509-20. PubMed ID: 4217380
    [No Abstract]   [Full Text] [Related]  

  • 38. Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin.
    Rubens CE; McGee ZA; Farrar WE
    J Infect Dis; 1980 Mar; 141(3):346-50. PubMed ID: 6988523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental chemotherapy of Proteus vulgaris infection].
    Nakazawa S; Yokota Y; Nishi H; Yoshida T; Yoshinaga M
    Jpn J Antibiot; 1968 Apr; 21(2):72-6. PubMed ID: 4299624
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular structure of an R factor, its component drug-resistance determinants and transfer factor.
    Milliken CE; Clowes RC
    J Bacteriol; 1973 Feb; 113(2):1026-33. PubMed ID: 4570588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.